977
A patient with chronic myeloid leukaemia treated with busulphan for 4-5 years, developed signs of busulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice.
 A patient with chronic myeloid leukaemia: Subject; busulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice: Effect; busulphan for 4-5 years: Treatment; 4-5 years: Treatment.Duration; busulphan: Treatment.Drug; chronic myeloid leukaemia: Treatment.Disorder
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 A patient with chronic myeloid leukaemia: Subject; busulphan toxicity and portal hypertension with ascites, oesophageal varices and jaundice: Effect; busulphan for 4-5 years: Treatment; 4-5 years: Treatment.Duration; busulphan: Treatment.Drug; chronic myeloid leukaemia: Treatment.Disorder